BNP Paribas Financial Markets
RPRX icon

BNP Paribas Financial Markets’s Royalty Pharma RPRX Stock Holding History

BNP Paribas Financial Markets’s Portfolio RPRX Stock Details RPRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$35.7M Buy
637,337
+243,612
+62% +$12.7M 0.01% 940
2026
Q1 		$18.9M Sell
393,725
-671,378
-63% -$29.4M 0.01% 1190
2025
Q4 		$41.2M Buy
1,065,103
+253,379
+31% +$9.66M 0.02% 781
2025
Q3 		$28.6M Sell
811,724
-118,942
-13% -$4.31M 0.02% 907
2025
Q2 		$33.5M Sell
930,666
-92,274
-9% -$3.06M 0.02% 770
2025
Q1 		$31.8M Sell
1,022,940
-621,864
-38% -$19.7M 0.02% 816
2024
Q4 		$42M Buy
+1,644,804
New +$43.6M 0.02% 694

Other funds holding RPRX

Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

BNP Paribas Financial Markets's RPRX Position: Q2 2026 in Review

BNP Paribas Financial Markets increased its Royalty Pharma (RPRX) stake by 62% in Q2 2026, buying an estimated $12.7M and bringing the position to 637,337 shares worth $35.7M. The position accounts for 0.01% of the portfolio, ranked #940.

BNP Paribas Financial Markets first reported a position in RPRX in Q4 2024 and has held it in 7 quarters since. The position peaked at $42M in Q4 2024. 647 funds tracked by Wall St. Rank hold RPRX as of Q2 2026.

  • BNP Paribas Financial Markets held 637,337 shares of Royalty Pharma worth $35.7M as of Q2 2026.
  • BNP Paribas Financial Markets bought 243,612 Royalty Pharma shares in Q2 2026, an estimated $12.7M.
  • Royalty Pharma made up 0.01% of BNP Paribas Financial Markets's portfolio in Q2 2026, its #940 holding.
  • BNP Paribas Financial Markets first reported a position in Royalty Pharma in Q4 2024 and has held it in 7 quarters since.
  • BNP Paribas Financial Markets's Royalty Pharma position peaked at $42M in Q4 2024.
  • 647 funds tracked by Wall St. Rank held Royalty Pharma as of Q2 2026.

Based on BNP Paribas Financial Markets's 13F filing for Q2 2026, filed 13 Aug 2026.